GoHealth (GOCO) Reports Q2 Loss, Lags Revenue Estimates

Financial Performance - GoHealth reported a quarterly loss of $0.75 per share, significantly better than the Zacks Consensus Estimate of a loss of $2.47, and an improvement from a loss of $1.77 per share a year ago, representing an earnings surprise of 69.64% [1] - The company posted revenues of $105.87 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 23.83%, and down from $142.78 million in the same quarter last year [2] - Over the last four quarters, GoHealth has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Stock Performance - GoHealth shares have declined approximately 13.4% since the beginning of the year, contrasting with the S&P 500's gain of 9% [3] - The current consensus EPS estimate for the upcoming quarter is -$2.52 on revenues of $132.56 million, and for the current fiscal year, it is -$5.26 on revenues of $744.68 million [7] Industry Outlook - The Insurance - Life Insurance industry, to which GoHealth belongs, is currently ranked in the bottom 38% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact GoHealth's stock performance [5]